AI Is Changing How Urologic Conditions Are Diagnosed and Treated
Using artificial intelligence tools in urology requires an open mind but with appropriate cautions according to clinicians and developers.
Using artificial intelligence tools in urology requires an open mind but with appropriate cautions according to clinicians and developers.
All information about registration for the 15th European Multidisciplinary Congress on Urological Cancers (EMUC23).
In the phase 3 RC48-C016 study, disitamab vedotin plus toripalimab significantly improved PFS and OS vs chemotherapy.
Policy availability varied by specialty, with urology leading in program-specific policies—yet still only at 11%.
Timothy D. McClure, MD, discusses focal therapy with IRE, specifically highlighting its benefits and limitations compared with other treatment options.
A phase 3 registrational trial of NDV-01 is expected in the first half of 2026.
A randomized controlled trial tested a model using donor-derived cell-free DNA for predicting graft rejection.
“It is common for a payer to request patient records when submitting for a service with a category III code,” write Jonathan Rubenstein, MD, and…
Abstracts information for AUA2026 in Washington, DC.
New findings from the PKIDS trial raise questions about the preference for ureteroscopy in clinical practice.
Call for Core Video Abstracts 2025InstructionsThe American Urological Association is now accepting teaching video abstracts for inclusion in the AUA Core Curriculum. Teaching video abstracts…